EICHORCondition: Alzheimer Disease · Sponsor: Eli Lilly and Company
The purpose of this study is to assess the safety, tolerability and effect of study drug LY3372689 in participants with early symptomatic Alzheimer's Disease
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Hope Clinical Research, Inc. | Canoga Park, California, United States | — |
| Neuro-Pain Medical Center | Fresno, California, United States | — |
| Irvine Clinical Research | Irvine, California, United States | — |
| Sharp Mesa Vista Hospital | San Diego, California, United States | — |
| Institute for Neurodegenerative Disorders | New Haven, Connecticut, United States | — |
| JEM Research Institute | Atlantis, Florida, United States | — |
| VIN-Julie Schwartzbard | Aventura, Florida, United States | — |
| Neurology Offices of South Florida | Boca Raton, Florida, United States | — |
| Brain Matters Research | Delray Beach, Florida, United States | — |
| Neuropsychiatric Research Center of Southwest Florida | Fort Myers, Florida, United States | — |
| K2 Medical Research | Maitland, Florida, United States | — |
| ClinCloud - Viera | Melbourne, Florida, United States | — |
+ 57 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05063539